Want to join the conversation?
For 1Q16, $EFX expects general corporate expense, excluding beta-related acquisition and integration expenses, to be $55-60MM and run at a slightly lower rate throughout the remaining quarters of the year. $EFX expects to see improvement in adjusted EBITDA margin in 2016 expanding by about 75BP. In 2016, GAAP effective tax rate will be about 33%.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.